False negativity to carbohydrate-deficient transferrin and drugs: A clinical case

6Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Introduction: In this work we report on the possible effect of the medical therapy on CDT concentration in a chronic alcohol abuser, with known medical history (July 2007 - April 2012) and alcohol abuse confirmed by relatives. Case history: At the end of 2007, patient displayed the following laboratory results: AST 137 U/L, ALT 120 U/L, GGT 434 U/L, MCV 101 fL and CDT 3.3%. On December 2007, after double coronary artery bypass surgery, he began a pharmacological treatment with amlodipine, perindopril, atorvastatin, isosorbide mononitrate, carvedilol, ticlopidine and pantoprazole. In the next months, until may 2011, the patient resumed alcohol abuse, as confirmed by relatives; however, CDT values were repeatedly found negative (0.8% and 1.1%) despite elevated transaminases and GGT, concurrent elevated ethyl glucuronide concentration (> 50 mg/L) and blood alcohol concentration (> 1 g/L). Alcohol consumption still continued despite increasing disulfiram doses ordered by an Alcohol Rehab Center. On May 2011, the patient was transferred to a private medical center where he currently lives. Conclusions: This study suggests the possibility that a medical therapy including different drugs may hamper the identification of chronic alcohol abusers by CDT. © by Croatian Society of Medical Biochemistry and Laboratory Medicine.

Cite

CITATION STYLE

APA

Vidali, M., Bianchi, V., Bagnati, M., Atzeni, N., Bianchi, A. M., & Bellomo, G. (2014). False negativity to carbohydrate-deficient transferrin and drugs: A clinical case. Biochemia Medica, 24(1), 175–179. https://doi.org/10.11613/BM.2014.020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free